How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

502,070 results for

(respiratory or pulmonary or lung or asthma or asthmatic or breathing)

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

81. Nitric oxide delivery during cardiopulmonary bypass reduces acute kidney injury: A randomized trial

at most: Send even when there aren't any new results Optional text in email: Save Cancel Create a file for external citation management software Create file Cancel Your RSS Feed Name of RSS Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Display options Display options Format Share Permalink Copy Page navigation J Thorac Cardiovasc Surg Actions . 2020 Jun 25;S0022-5223(20)31541-5. doi: 10.1016/j.jtcvs.2020.03.182. Online ahead of print. Nitric oxide delivery during (...) , Russia; Department of Cardiovascular Surgery, Siberian State Medical University, Tomsk, Russia. 4 Department of Anesthesiology and Critical Care, Meshalkin National Medical Research Center, Novosibirsk, Russia. PMID: 32718702 DOI: Item in Clipboard Nitric oxide delivery during cardiopulmonary bypass reduces acute kidney injury: A randomized trial Nikolay O Kamenshchikov et al. J Thorac Cardiovasc Surg . 2020 . Show details Display options Display options Format J Thorac Cardiovasc Surg Actions . 2020

2020 EvidenceUpdates

82. Modified Pectoral Nerve Block versus Serratus Block for Analgesia Following Modified Radical Mastectomy: A Randomized Controlled Trial Full Text available with Trip Pro

following modified radical mastectomy. Clinical trial registration: . Keywords: analgesics; breast cancer; mastectomy; modified radical; morphine; nerve block; pain management; pectoral nerves; thoracic nerves. © 2020 Bakeer et al. Conflict of interest statement The authors report no conflicts of interest in this work. Similar articles Wang W, Song W, Yang C, Sun Q, Chen H, Zhang L, Bu X, Zhan L, Xia Z. Wang W, et al. Pain Physician. 2019 Jul;22(4):E315-E323. Pain Physician. 2019. PMID: 31337173

2020 EvidenceUpdates

83. Incidence of venous and arterial thromboembolic events reported in the tofacitinib rheumatoid arthritis, psoriasis and psoriatic arthritis development programmes and from real-world data Full Text available with Trip Pro

pharmacovigilance of an ongoing, open-label, blinded-endpoint, tofacitinib RA trial (Study A3921133; ) in patients aged ≥50 years and with ≥1 cardiovascular risk factor identified a higher frequency of pulmonary embolism (PE) and all-cause mortality for patients receiving tofacitinib 10 mg twice daily versus those receiving tumour necrosis factor inhibitors and resulted in identification of a safety signal for tofacitinib. Here, we report the incidence of deep vein thrombosis (DVT), PE, venous thromboembolism

2020 EvidenceUpdates

84. Identification of very low-risk acute chest pain patients without troponin testing

Identification of very low-risk acute chest pain patients without troponin testing Identification of very low-risk acute chest pain patients without troponin testing - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 is an emerging, rapidly evolving situation. Get the latest public health information from CDC: . Get (...) new results Optional text in email: Save Cancel Create a file for external citation management software Create file Cancel Your RSS Feed Name of RSS Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Display options Display options Format Share Permalink Copy Page navigation Emerg Med J Actions . 2020 Aug 4;emermed-2020-209698. doi: 10.1136/emermed-2020-209698. Online ahead of print. Identification of very low-risk acute chest pain patients without troponin testing

2020 EvidenceUpdates

85. Recurrent venous thromboembolism during anticoagulation with edoxaban or warfarin: A post hoc analysis of the Hokusai-VTE trial

days, 39 of those during heparin lead-in. 23 of 147 patients died of pulmonary embolism (PE) during anticoagulation (case fatality rate 15.6%). 13 of those fatalities (57%) occurred during the first 30 days; 4 of those during heparin lead-in. The recurrence risk was numerically lower in patients assigned to edoxaban compared to those assigned to warfarin, particularly beyond 30 days. We observed a trend towards a higher proportion of men, high NT-proBNP levels and obesity at the time of diagnosis

2020 EvidenceUpdates

86. Clinical outcomes of 201 neonates born to mothers with COVID-19: a systematic review

Acute Respiratory Syndrome Coronavirus 2, SARS-CoV-2, Novel Coronavirus, 2019-nCov, Wuhan pneumonia) and (pregnancy, pregnant women, mother, fetus, neonate, newborn, infant). Results: We included 16 case series and 12 case reports describing a total of 223 pregnant women and 201 infants. Four newborns born to mothers affected by COVID-19 were reported to have laboratory-confirmed Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection within 48 hours after birth. However, Reverse (...) Transcription-Polymerase Chain Reaction tests of the breast milk, placenta, amniotic fluids, and cord blood and maternal vaginal secretions were all negative for SARS-CoV-2 in the reported cases. Fetal death was reported in two cases, and 48 of 185 newborns (25.9%) were born prematurely. Infants born small for gestational age and low birth weight (< 2,500 g) accounted for 8.3% and 15.6% of reported cases, respectively. Birth asphyxia and respiratory distress syndrome were observed in 1.8% and 6.4

2020 EvidenceUpdates

87. Association of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers with risk of COVID-19, inflammation level, severity, and death in patients with COVID-19: A rapid systematic review and meta-analysis Full Text available with Trip Pro

, and the risk of lower respiratory tract infections and lung injury: implications for COVID‐19. Cardiovasc Res. 2020. [published online ahead of print. 10.1093/cvr/cvaa097 - - - Show all 34 references Publication types Review Actions Related information Grant support LinkOut - more resources Full Text Sources Research Materials Miscellaneous Full-text links [x] [x] Citation text Copy Download .nbib Format: Send To [x] Connect National Center for Biotechnology Information Popular Resources Actions | | | (...) should be continued in patients who are at risk for, or have COVID-19, either in general population or hypertension patients. Our results need to be interpreted with caution considering the potential for residual confounders, and more well-designed studies that control the clinical confounders are necessary to confirm our findings. Keywords: ACEI/ARB; COVID-19; SARS-COV-2; hypertension; infectious disease; lung; pneumonia. © 2020 The Authors. Clinical Cardiology published by Wiley Periodicals LLC

2020 EvidenceUpdates

88. No Statistically Apparent Difference in Antiviral Effectiveness Observed Among Ribavirin Plus Interferon-Alpha, Lopinavir/Ritonavir Plus Interferon-Alpha, and Ribavirin Plus Lopinavir/Ritonavir Plus Interferon-Alpha in Patients With Mild to Moderate Coron Full Text available with Trip Pro

Health Medical Center, Chongqing, China. 3 Division of Tuberculosis, Chongqing Public Health Medical Center, Chongqing, China. 4 School of Biological Engineering, Chongqing University, Chongqing, China. PMID: 32765274 PMCID: DOI: Item in Clipboard Full-text links Cite Display options Display options Format Abstract Background: Currently, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread globally, causing an unprecedented pandemic. However, there is no specific antiviral therapy (...) , Wang, Yang and Chen. Figures Figure 1 5 Flow-chart of the study. Figure 1 13 Flow-chart of the study. Figure 1 Flow-chart of the study. Figure 2 5 Kaplan–Meier plot depicted in the… Figure 2 13 Kaplan–Meier plot depicted in the intention-to-treat population (A) and the per-protocol population (B)… Figure 2 Kaplan–Meier plot depicted in the intention-to-treat population (A) and the per-protocol population (B) . Figure 3 5 Percentage of severe acute respiratory… Figure 3 13 Percentage of severe acute

2020 EvidenceUpdates

89. The trade-off dilemma in pharmacotherapy of COVID-19: systematic review, meta-analysis, and implications

, Forty Fort , Danville, Pennsylvania, USA. 6 Division of Infectious Diseases, University of Nebraska Medical Center , Omaha, Nebraska, USA. PMID: 32752970 DOI: Item in Clipboard Full-text links Cite Display options Display options Format Abstract Introduction: The coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected millions of people worldwide and has contributed to over 650,000 deaths. This review synthesizes the literature

2020 EvidenceUpdates

90. COVID-19 infection in pregnant women, preterm delivery, birth weight, and vertical transmission: a systematic review and meta-analysis Full Text available with Trip Pro

Female Actions Humans Actions Infant, Newborn Actions Infectious Disease Transmission, Vertical* Actions Pandemics* Actions Pneumonia, Viral* / complications Actions Pneumonia, Viral* / transmission Actions Pregnancy Actions Pregnancy Complications, Infectious* Actions Premature Birth* Actions Supplementary concepts COVID-19 Actions severe acute respiratory syndrome coronavirus 2 Actions Related information LinkOut - more resources Full Text Sources Medical Miscellaneous Full-text links [x] [x

2020 EvidenceUpdates

91. Treatment options for ischemic mitral regurgitation: A meta-analysis

text in email: Save Cancel Create a file for external citation management software Create file Cancel Your RSS Feed Name of RSS Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Display options Display options Format Share Permalink Copy Page navigation J Thorac Cardiovasc Surg Actions . 2020 May 27;S0022-5223(20)31262-9. doi: 10.1016/j.jtcvs.2020.05.041. Online ahead of print. Treatment options for ischemic mitral regurgitation: A meta-analysis (...) for ischemic mitral regurgitation: A meta-analysis Francesco Nappi et al. J Thorac Cardiovasc Surg . 2020 . Show details Display options Display options Format J Thorac Cardiovasc Surg Actions . 2020 May 27;S0022-5223(20)31262-9. doi: 10.1016/j.jtcvs.2020.05.041. Online ahead of print. Authors , , , , , , , Affiliations 1 Department of Cardiac Surgery, Centre Cardiologique du Nord de Saint-Denis, Paris, France. Electronic address: francesconappi2@gmail.com. 2 Department of Vascular and Endovascular Surgery

2020 EvidenceUpdates

93. Ozone, air purifiers and asthma

to asthmatics. However, I have a patient that says this is true for the older units but the newer units ionize the air without causing ozone. Is there any truth to this? A: I looked online and in Pubmed and was not able to find any detailed information about certain brands. I asked Dr. David Peden who has an expertise in this area for his thoughts: "Many ionizers, especially older models, can generate ozone while they are operating. Ozone is known to exacerbate asthma. Manufacturers of many newer models (...) Ozone, air purifiers and asthma Ozone, air purifiers and asthma ') Cookie Notice This site uses cookies. By continuing to browse this site, you are agreeing to our use of cookies. Review our for more details. OK Menu Search Main navigation Utility navigation / Search navigation Search Search AAAAI Breadcrumb navigation ▸ ▸ Ozone, air purifiers and asthma | Ozone, air purifiers and asthma Q: 8/10/2020 I'm aware that A/C units add on ionizer modules can create ozone and thus be detrimental

2020 American Academy of Allergy, Asthma & Immunology - Ask the Expert

94. COVID-19 and IgG replacement therapy

53202-3823 Medical content developed and reviewed by the leading experts in allergy, asthma and immunology. © 2020 American Academy of Allergy, Asthma & Immunology. All Rights Reserved. | | Social navigation Mobile navigation Search navigation

2020 American Academy of Allergy, Asthma & Immunology - Ask the Expert

95. Pertussis reaction

parameter in evaluation of vaccine reactions which is very helpful resource. I hope this is helpful. Andrew Murphy, MD, FAAAAI Utility navigation Support the AAAAI Foundation 555 East Wells Street Suite 1100, Milwaukee , WI 53202-3823 Medical content developed and reviewed by the leading experts in allergy, asthma and immunology. © 2020 American Academy of Allergy, Asthma & Immunology. All Rights Reserved. | | Social navigation Mobile navigation Search navigation

2020 American Academy of Allergy, Asthma & Immunology - Ask the Expert

96. Horse immunotherapy

) and adjusted as the patient tolerates and symptoms dictate. I hope this is helpful. Andrew Murphy, MD, FAAAAI Utility navigation Support the AAAAI Foundation 555 East Wells Street Suite 1100, Milwaukee , WI 53202-3823 Medical content developed and reviewed by the leading experts in allergy, asthma and immunology. © 2020 American Academy of Allergy, Asthma & Immunology. All Rights Reserved. | | Social navigation Mobile navigation Search navigation

2020 American Academy of Allergy, Asthma & Immunology - Ask the Expert

97. Omalizumab and apremilast

is to move forward with omalizumab use in this patient then a thorough discussion of the lack of data and potential for untoward side effects should be undertaken and documented. I hope this is helpful. Andrew Murphy, MD, FAAAAI Utility navigation Support the AAAAI Foundation 555 East Wells Street Suite 1100, Milwaukee , WI 53202-3823 Medical content developed and reviewed by the leading experts in allergy, asthma and immunology. © 2020 American Academy of Allergy, Asthma & Immunology. All Rights

2020 American Academy of Allergy, Asthma & Immunology - Ask the Expert

98. Skin testing and dupilumab

, and this could potentially lead to loss of sensitization. In this scenario, the drug would not lead to a false negative, as the test would be negative because the patient was no longer making IgE against the allergen." I hope this is helpful, Andrew Murphy, MD, FAAAAI Utility navigation Support the AAAAI Foundation 555 East Wells Street Suite 1100, Milwaukee , WI 53202-3823 Medical content developed and reviewed by the leading experts in allergy, asthma and immunology. © 2020 American Academy of Allergy (...) , Asthma & Immunology. All Rights Reserved. | | Social navigation Mobile navigation Search navigation

2020 American Academy of Allergy, Asthma & Immunology - Ask the Expert

99. Metal testing

East Wells Street Suite 1100, Milwaukee , WI 53202-3823 Medical content developed and reviewed by the leading experts in allergy, asthma and immunology. © 2020 American Academy of Allergy, Asthma & Immunology. All Rights Reserved. | | Social navigation Mobile navigation Search navigation

2020 American Academy of Allergy, Asthma & Immunology - Ask the Expert

100. Mold allergy

, FAAAAI Utility navigation Support the AAAAI Foundation 555 East Wells Street Suite 1100, Milwaukee , WI 53202-3823 Medical content developed and reviewed by the leading experts in allergy, asthma and immunology. © 2020 American Academy of Allergy, Asthma & Immunology. All Rights Reserved. | | Social navigation Mobile navigation Search navigation

2020 American Academy of Allergy, Asthma & Immunology - Ask the Expert

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>